These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, Räber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, Lüscher TF. Eur Heart J; 2017 Mar 14; 38(11):814-824. PubMed ID: 28077467 [Abstract] [Full Text] [Related]
4. Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Guertin KA, Li XS, Graubard BI, Albanes D, Weinstein SJ, Goedert JJ, Wang Z, Hazen SL, Sinha R. Cancer Epidemiol Biomarkers Prev; 2017 Jun 14; 26(6):945-952. PubMed ID: 28077427 [Abstract] [Full Text] [Related]
5. Distinguishing benign and malignant thyroid nodules using plasma trimethylamine N-oxide, carnitine, choline and betaine. Shi L, Guo M, Shi C, Gao G, Xu X, Zhang C, Fu J, Ni Y, Wang F, Xue X, Yu F. J Cancer Res Clin Oncol; 2024 Mar 20; 150(3):142. PubMed ID: 38503944 [Abstract] [Full Text] [Related]
7. Serum neurofilament light chain in functionally relevant coronary artery disease and adverse cardiovascular outcomes. Amrein M, Meier S, Schäfer I, Schaedelin S, Willemse E, Benkert P, Walter J, Puelacher C, Zimmermann T, Median D, Egli C, Leppert D, Twerenbold R, Zellweger M, Kuhle J, Mueller C. Biomarkers; 2023 May 20; 28(3):341-351. PubMed ID: 36714921 [Abstract] [Full Text] [Related]
8. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Mueller DM, Allenspach M, Othman A, Saely CH, Muendlein A, Vonbank A, Drexel H, von Eckardstein A. Atherosclerosis; 2015 Dec 20; 243(2):638-44. PubMed ID: 26554714 [Abstract] [Full Text] [Related]
9. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study. Tang WHW, Li XS, Wu Y, Wang Z, Khaw KT, Wareham NJ, Nieuwdorp M, Boekholdt SM, Hazen SL. Am Heart J; 2021 Jun 20; 236():80-86. PubMed ID: 33626384 [Abstract] [Full Text] [Related]
10. Gut microbiota metabolites and risk of major adverse cardiovascular events and death: A systematic review and meta-analysis. Khan QA, Asad M, Ali AH, Farrukh AM, Naseem U, Semakieh B, Levin Carrion Y, Afzal M. Medicine (Baltimore); 2024 May 31; 103(22):e37825. PubMed ID: 39259062 [Abstract] [Full Text] [Related]
11. Choline metabolites and incident cardiovascular disease in a prospective cohort of adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study. Shea JW, Jacobs DR, Howard AG, Lulla A, Lloyd-Jones DM, Murthy VL, Shah RV, Trujillo-Gonzalez I, Gordon-Larsen P, Meyer KA. Am J Clin Nutr; 2024 Jan 31; 119(1):29-38. PubMed ID: 37865185 [Abstract] [Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor and functionally relevant coronary artery disease: a prospective cohort study. Walter JE, Amrein MLF, Schäfer I, Zimmermann T, Lopez-Ayala P, Boeddinghaus J, Twerenbold R, Puelacher C, Nestelberger T, Wussler D, Honegger U, Badertscher P, Eugen-Olsen J, Koechlin L, Fahrni G, Jeger R, Kaiser C, Zellweger M, Mueller C. Biomarkers; 2022 May 31; 27(3):278-285. PubMed ID: 35112976 [Abstract] [Full Text] [Related]
15. Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults. Fretts AM, Hazen SL, Jensen P, Budoff M, Sitlani CM, Wang M, de Oliveira Otto MC, DiDonato JA, Lee Y, Psaty BM, Siscovick DS, Sotoodehnia N, Tang WHW, Lai H, Lemaitre RN, Mozaffarian D. JAMA Netw Open; 2022 May 02; 5(5):e2213242. PubMed ID: 35594043 [Abstract] [Full Text] [Related]
16. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection. Haissman JM, Haugaard AK, Ostrowski SR, Berge RK, Hov JR, Trøseid M, Nielsen SD. BMC Infect Dis; 2017 Jun 23; 17(1):445. PubMed ID: 28645263 [Abstract] [Full Text] [Related]
17. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice. Yu ZL, Zhang LY, Jiang XM, Xue CH, Chi N, Zhang TT, Wang YM. J Food Sci; 2020 Jul 23; 85(7):2207-2215. PubMed ID: 32572979 [Abstract] [Full Text] [Related]
18. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure. Tang WH, Wang Z, Shrestha K, Borowski AG, Wu Y, Troughton RW, Klein AL, Hazen SL. J Card Fail; 2015 Feb 23; 21(2):91-6. PubMed ID: 25459686 [Abstract] [Full Text] [Related]
19. Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies. Heianza Y, Ma W, Manson JE, Rexrode KM, Qi L. J Am Heart Assoc; 2017 Jun 29; 6(7):. PubMed ID: 28663251 [Abstract] [Full Text] [Related]
20. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults. Lee Y, Nemet I, Wang Z, Lai HTM, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Sotoodehnia N, Budoff M, DiDonato JA, McKnight B, Tang WHW, Psaty BM, Siscovick DS, Hazen SL, Mozaffarian D. J Am Heart Assoc; 2021 Sep 07; 10(17):e020646. PubMed ID: 34398665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]